Tag: report

WEST DES MOINES, Iowa, June 24, 2025 (GLOBE NEWSWIRE) -- Athene Holding Ltd. (“Athene”) today announced it has agreed to sell $600 million aggregate principal amount of 6.875% fixed-rate reset junior subordinated debentures due June 28, 2055. The offering is expected to close on June 27, 2025, subject to satisfaction of customary closing conditions.

Following the reverse share split, the Company will have approximately 534,600 outstanding shares, out of which approximately 516,727 will be publicly held

CALGARY, Alberta, June 24, 2025 (GLOBE NEWSWIRE) -- Canacol Energy Ltd. ("Canacol" or the "Corporation") (TSX:CNE) (OTCQX:CNNEF) (BVC:CNEC) is pleased to announce that at the annual general and special meeting held in Bogotá, Colombia‎ on June 24, 2025 (the "Meeting") holders of common shares of Canacol: (i) elected Charle Gamba, Michael Hibberd, Francisco Diaz, Gustavo Gattass, Valentina Garbarini, Silvestre Tovar Leopardi and David Winter to the Board of Directors; (ii) appointed PricewaterhouseCoopers LLP, as Canacol's auditors; and (iii) approved the unallocated awards under the Corporation's omnibus long-term incentive plan.

LONG BEACH, Calif. and TORONTO, June 24, 2025 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF), one of the fastest-growing, vertically integrated cannabis companies in the U.S., announces that, at the Company's annual and special meeting (the "Meeting") of shareholders that was held on June 20, 2025 at 11:00 a.m. (Pacific Time), the Company's shareholders passed all of the resolutions put before them.

CUE-401, a first-in-class bispecific molecule designed to induce and expand Tregs in vivo through the co-activity of transforming TGF-β and a modified variant of IL-2

ARCHBOLD, Ohio, June 24, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Farmers & Merchants Bancorp, Inc., (Nasdaq: FMAO) the holding company of F&M Bank, with total assets of $3.39 billion at March 31, 2025, today announced that it has approved the Company’s quarterly cash dividend of $0.22125 per share. The second-quarter dividend is payable on July 20, 2025, to shareholders of record as of July 7, 2025.  

NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. ("Rocket" or the "Company") (NASDAQ: RCKT) of a class action securities lawsuit.

Company to discuss second quarter earnings on August 5th